Didanosine
- 1 July 1992
- journal article
- clinical trial
- Published by Springer Nature in Drugs
- Vol. 44 (1) , 94-116
- https://doi.org/10.2165/00003495-199244010-00008
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- Population Pharmacokinetic Analysis of Didanosine (2′,3′‐Dideoxyinosine) Plasma Concentrations Obtained in Phase I Clinical Trials in Patients with AIDS or AIDS‐Related ComplexThe Journal of Clinical Pharmacology, 1992
- 1-β-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) and 5-ethynyl-1-β-D-ribofuranosylimidazole-4-carboxamide (EICAR) markedly potentiate the inhibitory effect of 2′,3′-dideoxyinosine on human immunodeficiency virus in peripheral blood lymphocytesBiochemical and Biophysical Research Communications, 1991
- Long-term toxicity/activity profile of 2',3'-dideoxyinosine in AIDS or AIDS-related complexThe Lancet, 1990
- Biology of retroviruses: Detection, molecular biology, and treatment of retroviral infectionJournal of the American Academy of Dermatology, 1990
- The Efficacy of Inosine Pranobex in Preventing the Acquired Immunodeficiency Syndrome in Patients with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1990
- 2′,3′-Dideoxyinosine (ddI) in Patients with the Acquired Immunodeficiency Syndrome or AIDS-Related ComplexNew England Journal of Medicine, 1990
- GanciclovirDrugs, 1990
- Bone Marrow Toxicity of DideoxyinosineNew England Journal of Medicine, 1989
- Clinical Pharmacology of 3'-Azido-2',3'-Dideoxythymidine (Zidovudine) and Related DideoxynucleosidesNew England Journal of Medicine, 1989
- ZidovudineDrugs, 1989